PremiumThe FlyPrometheus downgraded to Equal Weight from Overweight at Wells Fargo Prometheus downgraded to Sector Perform from Outperform at RBC Capital Prometheus downgraded to Neutral from Outperform at Credit Suisse PremiumThe FlyPrometheus downgraded to Hold from Buy at Stifel Prometheus downgraded to Neutral from Buy at BTIG Merck Acquiring Prometheus Biosciences PremiumThe FlyPrometheus price target raised to $138 from $114 at Piper Sandler Prometheus price target raised to $150 from $125 at Oppenheimer Prometheus reports Q4 EPS (90c), consensus (92c) 
